HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Structural heart disease

Reverse Myocardial Remodeling Following Valve Replacement

After aortic valve replacement, focal fibrosis does not resolve, but diffuse fibrosis and cell hypertrophy regress. As...
solaci -
Learn More
STRUCTURAL HEART DISEASE

NOTION: 5-Year Outcomes of TAVR vs. Surgery in Low-Risk Patients are Promising

At 5 years, there were no differences in all-cause death, stroke, acute myocardial infarction, or all of these...
solaci -
Learn More
Structural heart disease

Permanent Pacemaker: still TAVR’s Aquila’s Heel

TAVR has shown benefits in high risk patients (prohibitive) and in intermediate risk patients, but the need for permanent...
solaci -
Learn More
Structural heart disease

Next-Day Discharge after TAVR: Is It Viable?

Next-day discharge after transfemoral transcatheter aortic valve replacement (TAVR) might be viable, with no major complications at 30 days...
solaci -
Learn More
Structural heart disease

Red Light for TAVR in Low Surgical Risk Patients

A new study raises an alarm against expanding transcatheter aortic valve replacement (TAVR) procedures to low surgical risk...
solaci -
Learn More
Structural heart disease

Is Emergency Cardiac Surgery Necessary in TAVR?

Life-threatening complications that require surgery during TAVR are infrequent. The proportion was originally thought to be between...
solaci -
Learn More
Coronary disease

Coronary Disease Works as a 30-Day Predictor in TAVR

The association between aortic stenosis and coronary disease is common, since both conditions share pathogenesis, risk factors,...
solaci -
Learn More
Structural heart disease

Leading Manufacturer of Balloon-Expandable Valves Launches Self-Expanding Device

Edwards Lifesciences could have been satisfied after the success of the PARTNER trials and the improvements to...
solaci -
Learn More